Cara Care vs Aidy: Which Crohn's App Matches the Diagnosis?

Aidy is built for diagnosed Crohn's tracking, while Cara Care's listing describes an IBS-focused digital therapy with nutrition tools and separate eligibility, access, and pricing requirements depending on where and how each person receives their care.

Quick answer: Choose Aidy as the primary tracker for diagnosed Crohn's because its free workflow connects symptoms, stool, meals, medicines, biologic schedules, modified HBI trends, and reports. Cara Care is the genuine exception when a clinician has separately diagnosed IBS and the person qualifies for the German prescription therapy its public materials describe.

Decision factor	Aidy	Cara Care (public claims)
Best for	Diagnosed Crohn's management	Eligible diagnosed IBS care
Daily IBD record	Symptoms, stool, meals, medicines	IBS-focused exercises and logs
Treatment tools	Adherence and biologic workflows	Prescription therapy program
Reports and insights	Modified HBI trends and reports	IBS program progress
Access and cost	Free; iPhone or text	German eligibility determines access
Overall pick	Primary Crohn's tracker	Coexisting-IBS exception

Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.

There Are Two Cara Care Stories Online

The current Cara Care website answers Cara Care price questions: it says the IBS therapy app is free on prescription, reimbursed in Germany, and available only in German. Its current Google Play listing requires an activation code and says it limits the IBS program to adults ages 18 through 70 with a medical diagnosis. The developer says the program combines a food and symptom diary with low-FODMAP guidance, recipes, gut-directed hypnosis, education, and modules addressing emotions and behavior. It also says users can record stool, stress, sleep, exercise, skin, and menstrual information.

US searches surface a legacy iPhone listing. It describes a broad IBS and IBD tracker plus a 12-week dietitian-supported program, but its latest listed release is from October 2020. The corresponding legacy Android listing also shows an October 2020 update.

IBS vs Crohn's tracking app: diagnosis still matters

A systematic review and meta-analysis found IBS-type symptoms in 32.5% of people with IBD in remission, with a pooled estimate of 36.6% in Crohn's disease. Cara Care's diet, stress, and mind-body tools may therefore be relevant for a person whose gastroenterologist has identified an IBS overlap.

A low FODMAP app for IBD needs context. In a randomized trial of 52 people with quiescent IBD and persistent gut symptoms, more participants reported adequate symptom relief after four weeks of low-FODMAP advice than after control advice, while inflammation markers did not differ significantly. Another randomized IBD trial studied patients with coexisting IBS-like symptoms; it did not test the diet as Crohn's treatment. It should not be used to infer whether Crohn's inflammation is active.

Aidy Covers the Crohn's Treatment Timeline

Aidy records meals by text or photo, Bristol stool type, symptom severity, custom symptoms, and medication adherence. It also includes induction and maintenance schedules for common IBD biologics, dose countdowns, reminders, injection-site rotation, post-injection or infusion check-ins, and support for route or interval changes. Cara Care claims broader diaries across lifestyle factors, but its public materials do not describe an equivalent biologic workflow.

Aidy also turns daily entries into a modified Harvey-Bradshaw Index trend for Crohn's and doctor-ready reports. HBI is a symptom-based index with known limitations when compared with the more complex Crohn's Disease Activity Index (validation study). NIDDK describes blood and stool tests, endoscopy, and imaging as components of Crohn's assessment, while the AGA biomarker guideline recommends combining symptoms with biomarkers in several monitoring situations.

Access, Price, and Privacy Need a Current Check

Its US iPhone page lists a free download, a two-week trial, and $89.99 premium purchases. Because that listing has not shown an update since 2020, its price and advertised dietitian program should be treated as legacy storefront information. The current German Google Play page says personal data is stored on Western European servers, reports no third-party sharing, and says health and other data may be collected.

Aidy is available as an iPhone app and through SMS in the United States. Aidy is free to use, has no paid user subscriptions, carries no ads, and does not sell user data. Review device permissions before adding health information.

The Better Choice for Crohn's Disease

Cara Care is the more developed therapy program for eligible German adults with medically diagnosed IBS. Its materials claim richer structured content around low-FODMAP eating, recipes, stress, and gut-directed hypnosis. Someone with objectively controlled Crohn's plus clinician-confirmed IBS-type symptoms could reasonably use those tools alongside IBD care. The stale US listings and activation requirements make Cara Care a poor default recommendation for a US Crohn's tracker.

Aidy is the better fit for Crohn's disease itself. It keeps food and symptom patterns in the same timeline as adherence, biologic dosing, tolerability, disease-activity trends, and appointment reports. That integrated record matches the ongoing work of managing diagnosed inflammatory disease. Aidy's free model also removes the advertised $89.99 Cara Care premium barrier. For primary Crohn's tracking, Aidy wins; Cara Care is a specialized complement for a separate, confirmed IBS problem.